Identification and functional validation of novel autoantigens in equine uveitis.

The research article focuses on discovering and testing the role of new autoantigens in equine recurrent uveitis, an autoimmune disease in horses, by examining the pattern of autoantibody binding to the retinal proteome. The study’s key finding was the identification of cellular retinaldehyde-binding protein (cRALBP) as an autoantigen and its impact on the progression of the disease.

Identification of Novel Autoantigens

• The researchers started by analyzing the pattern of autoantibody binding to the retinal proteome from horses affected by equine recurrent uveitis. This disease, a common cause of blindness in horses, is marked by repeated inflammatory episodes targeting the uvea, a layer of the horse’s eye.
• The goal was to identify new autoantigens, a group of substances that trigger an immune response, contributing to the development and progression of autoimmune diseases.

Characterization of cRALBP as an Autoantigen

• The researchers discovered that Cellular Retinaldehyde-Binding Protein (cRALBP) had not been previously identified as an autoantigen.
• Further analysis in horses with equine recurrent uveitis revealed B and T cell autoreactivity to this protein, establishing a link to a phenomenon termed ‘epitope spreading’.
• ‘Epitope spreading’ refers to the diversification of an autoimmune response to multiple epitopes, regions of a protein that antibodies can recognize and bind to, following the initial disease-triggering immune response.

Functional Validation of cRALBP as an Autoantigen

• The study didn’t stop at characterizing cRALBP as an autoantigen. The next step was to validate the role of this protein in causing uveitis.
• To do this, researchers immunized healthy rats and horses with cRALBP, subsequently observing the development of uveitis in both species, with typical tissue lesions at sites expressing cRALBP.
• This outcome thus validated the role of cRALBP as an autoantigen inducing uveitis.

Potential Applications of the Study

• The profiling approach used in this study to identify and test autoantigens can be applied to various autoimmune diseases.
• By identifying autoantigens participating in ‘epitope spreading’, this approach can help tracking the dynamic progression of autoimmune diseases, or even serve as markers to predict the disease.